Cargando…
Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry
SIMPLE SUMMARY: Lumican, a small leucine-rich proteoglycan (SLRP), maintains extracellular matrix (ECM) integrity while inhibiting melanoma primary tumor development, as well as metastatic spread. The aim of this study was to analyze the effect of lumican on tumor growth of murine ovarian carcinoma....
Autores principales: | Nizet, Pierre, Untereiner, Valérie, Sockalingum, Ganesh D., Proult, Isabelle, Terryn, Christine, Jeanne, Albin, Nannan, Lise, Boulagnon-Rombi, Camille, Sellier, Christèle, Rivet, Romain, Ramont, Laurent, Brézillon, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656468/ https://www.ncbi.nlm.nih.gov/pubmed/34885059 http://dx.doi.org/10.3390/cancers13235950 |
Ejemplares similares
-
Label-Free Infrared Spectral Histology of Skin Tissue Part I: Impact of Lumican on Extracellular Matrix Integrity
por: Nannan, Lise, et al.
Publicado: (2020) -
Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth
por: Brézillon, Stéphane, et al.
Publicado: (2020) -
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
por: Jeanne, Albin, et al.
Publicado: (2017) -
Investigation of Glypican-4 and -6 by Infrared Spectral Imaging during the Hair Growth Cycle
por: Colin-Pierre, Charlie, et al.
Publicado: (2023) -
Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers
por: Karamanou, Konstantina, et al.
Publicado: (2021)